Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
234.00    -12.50 (-4.91%)
Bid:
236.00
Ask:
248.00
Spread: 12.00 (5.085%)
Market Cap: £25.69m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Loan Conversion

9 Dec 2025 11:40

RNS Number : 8585K
Alkemy Capital Investments PLC
09 December 2025
 

9 December 2025

 

Alkemy Capital Investments Plc

Loan Conversion

 

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £250,000 of principal and £513.70 of interest is being converted at £2.77, resulting in the issue of 90,572 ordinary shares of 2 pence each in the Company ("Ordinary Shares").

The Company will accordingly issue 90,572 new Ordinary Shares in the Company (the "New Ordinary Shares").

Admission

Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 15 December 2025 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 10,662,592 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is committed to supplying battery-grade lithium chemicals to meet the growing demand of the electric vehicle supply chain in Europe. Strategically located at in Teesside, UK, TVL is developing a low-carbon, independent lithium supply chain for European battery manufacturers.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFKLFBELLXFBZ
Date   Source Headline
20th Jan 20147:00 amRNSTrading Update and Notice of Results
16th Jan 20147:00 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSHolding(s) in Company
9th Jan 201410:06 amRNSTR-1: Notification of Major Interest in Shares
24th Dec 20131:29 pmRNSTotal Voting Rights
9th Dec 20134:38 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSChange of Nominated Adviser
24th Oct 20131:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20132:15 pmRNSAward of Performance Shares
11th Sep 20137:00 amRNSInterim Results
8th Aug 20137:50 amRNSHolding(s) in Company
8th Aug 20137:50 amRNSHolding(s) in Company
5th Aug 201311:26 amRNSAcquisition of Licence
24th Jul 201310:55 amRNSAcquisition of Licence and Third Party Royalty
9th Jul 20137:00 amRNSNotice of Results and Trading Update
28th May 20133:13 pmRNSHolding(s) in Company
28th May 20132:15 pmRNSAward of Performance Shares
28th May 201310:13 amRNSHolding(s) in Company
24th May 20139:29 amRNSCompletion of Acquisition and Fundraising
24th May 20139:28 amRNSTotal Voting Rights
23rd May 201311:48 amRNSHolding(s) in Company
22nd May 20137:00 amRNSAcquisition and Fundraising
16th May 201310:18 amRNSGrant of SAYE Share Options
1st May 20132:58 pmRNSAppointment of Joint Broker
1st May 20132:36 pmRNSResult of AGM
1st May 20137:00 amRNSAGM Statement and Trading Update
22nd Apr 20137:00 amRNSPublication of Report & Accounts
18th Apr 201311:48 amRNSHolding(s) in Company
12th Apr 201312:54 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNSPreliminary results
6th Feb 201310:09 amRNSHolding(s) in Company
18th Jan 20137:00 amRNSNotice of Results and Trading Update
16th Jan 201310:06 amRNSAdditional Listing
6th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Oct 201212:28 pmRNSHolding(s) in Company
26th Oct 201211:24 amRNSTotal Voting Rights
25th Oct 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 20127:00 amRNSAdditional Listing
11th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:02 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSDirectorate Change
21st Sep 20127:00 amRNSGrant of Share Options
12th Sep 20127:00 amRNSInterim Results
3rd Sep 20128:53 amRNS£1.6m Biogas Contract
29th May 201212:28 pmRNSResult of AGM
29th May 20127:00 amRNSTrading Statement
14th May 20129:59 amRNSHolding(s) in Company
10th May 20129:20 amRNSTotal Voting Rights
8th May 201210:15 amRNSHolding(s) in Company
3rd May 20128:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.